Dysphagia secondary to peripheral cranial nerve injury originates from weak and uncoordinated contraction-relaxation of cricopharyngeal muscle. We report on two patients who suffered vagus nerve injury during surgery and showed sudden dysphagia by opening dysfunction of upper esophageal sphincter (UES). Videofluoroscopy-guided balloon dilatation of UES was performed. We confirmed an early improvement of the opening dysfunctions of UES, although other neurologic symptoms persisted. While we did not have a proper comparison of cases, the videofluoroscopy-guided balloon dilatation of UES is thought to be helpful for the early recovery of dysphagia caused by postoperative vagus nerve injury.
A total of 217 cases were operated upon for pulmonary tuberculosis, among these, 152 were operated in the 4 year period between 1956 to 1959. There were 134 resection and 83 thoracoplasties, the ratio being 1.6:1. The over-all operative mortality of 217 cases was 1,8%; the operative mortality for resection being 2.2% and for thoracoplasty 1.2%. Major complications arose in 14 or 10.4% of the entire resected cases and, among these, empyema with or without bronchopleural fistula was the most prominent feature(6%). However, all of these responded favorable to intercostal drainage alone or in combination with a small-scale thoracoplasty. 82 patients were followed from 6 months to 4 years after surgery, Among these, 68 reached an inactive stagem 13 remained active and 1 died 9 months and uremia. Follwing factors, among others seem to influence the outcome of operation in a significant way.1. Patients in the age group of 21 to 30 appeared to do poorly(79.0% inactive state) as compared to either younger or older patients.2. The severity of the disease had a definite bearing on the outcome of the operation. In far advanced cases, the patients who reached inactive stage was only 80.8% as compared to 85.7% in moderately advanced and 100% in minimal cases.3. Cases who showed positive sputum preoperatively showed poorer result(82.8% inactive state) than sputum negative cases(90.0% inactive state)4. There was essentially no difference between resection and thoracoplasty as far as the results are concerned. Following resection, 82.6% reached inactive state as compared to 83.4% in thoracoplasty. Also the patients remaining active were 15.4% in the resected cases and 16.6% in thoracoplasty patients.5. Patients who underwent surgery during the first 2 years of disease did poorly as compared to those whoo had surgery after 2 or more years of disease. This seem to indicate that the latter group obtained better result because of their natural resistance against tuberculosis. Majority of these patients were operated on under no sanatorium care, after prolonged irregular anti-tuberculosis therapy and in highly advanced state. Even under this unfavorable conditions, the results appear to be acceptable. In this series, the outcome following thoracoplasty is equal to or even superior to pulmonary resection, particularly in view of the fact that thoracoplasty cases were much more advanced than the cases selected for resection. It is suggested that resectional therapy be retained as the procedure of choice in selected cases and that thoracoplasty be reserved as a procedure which and be highly effective in cases whose disease condition is less amenable for resection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.